G2211 Longitudinal Complexity Attestation for Infertility Management: The 2026 Reproductive Endocrinology Operations Playbook

G2211 is billable in reproductive endocrinology when the REI physician serves as the continuing focal point for a serious or complex reproductive condition, the office E/M is not appended with Modifier 25 for a same-day procedure, and the note attests to a longitudinal relationship, a named condition, and a forward treatment plan.

G2211 pays for the longitudinal relationship, not the complexity of a single visit

The Centers for Medicare & Medicaid Services created HCPCS add-on code G2211 to recognize the cognitive and relational burden of being the practitioner a patient depends on over time. It attaches to office and outpatient E/M codes 99202 through 99215 and, since 2025, to home or residence visits 99341 through 99350. It does not attach to inpatient, observation, or emergency department services.

The code's official descriptor covers visit complexity inherent to E/M care that is either (1) the continuing focal point for all needed health care services, or (2) part of ongoing care for a single, serious condition or a complex condition. Reproductive endocrinology and infertility (REI) practices almost always qualify under the second prong, not the first.

National payment is roughly sixteen dollars per claim line, adjusted by geographic practice cost index. That figure looks small until it is multiplied across a practice that sees the same patients six to twelve times per treatment arc. For a three-physician REI group, consistent capture on eligible encounters can represent a meaningful annual revenue line without adding a single appointment slot.

CMS has stated that the relationship, not the visit, is the billable unit of meaning. A first visit can qualify if the documented intent is to manage the condition over time. A single second-opinion consult with no planned follow-up does not qualify, even if the visit itself was complex.

Three conditions must be true on every G2211 claim

• A longitudinal relationship exists or is clearly initiated, with the REI practice managing the condition across encounters.

• A serious or complex condition is named in the assessment and supported by the ICD-10-CM codes on the claim.

• No Modifier 25 procedure conflict exists on the same date of service, outside the narrow preventive-service exception.

Infertility qualifies as a serious or complex condition when the REI practice owns the diagnostic and treatment arc

Infertility is rarely a single diagnosis. It is typically a convergence of endocrine, anatomic, genetic, and immunologic findings that require sequential testing, iterative protocol adjustment, and repeated risk counseling. That structure matches the CMS concept of a complex condition managed over time far better than many primary care scenarios.

Anovulatory infertility is the clearest example. A patient coded with N97.0 (ICD-10-CM), female infertility associated with anovulation, frequently carries a parallel diagnosis of polycystic ovary syndrome (E28.2), insulin resistance, or hyperprolactinemia (E22.1). Each requires ongoing titration of letrozole, metformin, or dopamine agonists, plus cycle-by-cycle reassessment.

Recurrent pregnancy loss is another strong anchor. A patient coded with N96 (ICD-10-CM), recurrent pregnancy loss, needs a structured workup (karyotyping, antiphospholipid testing, uterine cavity evaluation, thyroid and glucose assessment) followed by surveillance in the next conception attempt. The REI physician is the clinician holding that entire plan together.

High-yield REI diagnoses for G2211 anchoring

• Anovulation and PCOS phenotypes: N97.0 with E28.2, often with metabolic comorbidity codes.

• Recurrent pregnancy loss workups: N96 with supporting thrombophilia, uterine, or genetic codes.

• Premature ovarian insufficiency: E28.31x subcategories, which also require bone and cardiovascular counseling.

• Endometriosis-associated infertility: N80.x with N97.8 or N97.9 as clinically appropriate.

• Tubal factor infertility: N97.1, particularly when surgical versus IVF decisions span several visits.

• Hypothalamic amenorrhea: E23.x or related codes when gonadotropin therapy is managed over time.

Z31 encounter codes should not stand alone as the G2211 anchor. Codes such as Z31.41 (fertility testing) or Z31.83 (assisted reproductive fertility procedure cycle) describe the encounter purpose, not the underlying serious condition. Sequence them alongside the condition code so the claim tells a coherent clinical story.

Medical directors building a coding reference for their teams can pull condition-specific templates from the Specialty Clinical Documentation Library, which maps REI diagnoses to the assessment language auditors expect to see.

Payer mix determines whether G2211 capture is a priority or a footnote in REI

Most REI revenue is commercial or self-pay. Traditional Medicare generally excludes assisted reproductive technology, though it may cover diagnostic evaluation and treatment of underlying conditions that are reasonable and necessary. Medicare-eligible REI patients are typically under 65 with disability-based entitlement, or they are seen for conditions such as POI, hyperprolactinemia, or menopause-adjacent endocrine disorders.

Commercial and Medicaid adoption varies by contract. Some plans recognize G2211 and pay it at a percentage of the Medicare rate. Others deny it as a non-covered HCPCS code. Several Medicaid programs have adopted it; others have not. Your billing team should maintain a payer-level policy matrix and update it every January and July.

California practices face a shifting landscape in 2026. California SB 729 expanded infertility and fertility-preservation coverage requirements for large group health plans, with implementation timing that moved to January 1, 2026. More covered infertility visits means more commercial claims where G2211 policy matters. Confirm each plan's position before building automated capture rules.

Recommended payer policy matrix fields

• Payer and plan type: commercial, Medicare Advantage, Medicaid managed care, traditional Medicare.

• G2211 recognition status: paid, denied as non-covered, or bundled into base E/M.

• Infertility benefit status: diagnostic only, treatment covered, or ART covered.

• Patient liability exposure: whether G2211 triggers coinsurance the patient must be informed about.

Patient cost-sharing deserves explicit attention. G2211 is subject to standard Part B coinsurance and deductible. Patients who are already stretched by out-of-pocket fertility costs notice line items they do not recognize. A one-sentence financial counseling script ("this code reflects our team's ongoing management of your condition") reduces billing office call volume.

Modifier 25 on a same-day procedure eliminates G2211 eligibility for that encounter

This rule causes more REI denials than any other. CMS does not pay G2211 when the associated office E/M is reported with Modifier 25, except when the separately reported same-day service is an annual wellness visit, vaccine administration, or a Medicare Part B preventive service. That exception took effect in 2025 and remains in place for 2026.

REI clinics perform many minor procedures with zero-day or ten-day global periods on the same day as an evaluation. Intrauterine insemination (58322), endometrial biopsy (58100), saline infusion sonohysterography (58340 with imaging 76831), and office hysteroscopy (58555, 58558) all commonly trigger Modifier 25 when a separately identifiable E/M is also billed.

Diagnostic ultrasound is different. Transvaginal pelvic ultrasound (76830) and follicle monitoring studies are diagnostic tests without a global surgical period. Billing them on the same day as an E/M does not require Modifier 25. A visit consisting of a significant E/M plus a diagnostic ultrasound can still carry G2211, provided the other criteria are met.

Same-day scheduling decisions that protect G2211

• Separate complex counseling from procedures: schedule protocol-planning visits on non-procedure days when clinically reasonable.

• Never split visits solely for billing: patient convenience and clinical need must drive scheduling, not add-on capture.

• Flag Modifier 25 encounters automatically: charge capture rules should suppress G2211 when 25 is present.

• Review preventive exceptions carefully: cervical cancer screening services may fall under the preventive exception.

Rule of thumb: Modifier 25 present means G2211 suppressed, unless preventive.

Defensible attestation language names the condition, the relationship, and the forward plan

CMS does not mandate a specific attestation statement. It has said the medical record, claims history, diagnoses, and the practitioner's assessment and plan should support the longitudinal relationship. In practice, auditors and commercial payer reviewers look for explicit language. A short, structured attestation removes ambiguity.

An effective REI attestation contains four elements: the named serious or complex condition, a statement that the practitioner is managing that condition over time, a reference to prior or planned encounters, and a concrete next step. Generic templated phrases ("patient seen for ongoing care") are weaker because they could apply to any visit.

Sample attestation for anovulatory infertility

"I am the reproductive endocrinologist providing ongoing longitudinal management of this patient's anovulatory infertility (N97.0) secondary to PCOS (E28.2). Today's visit continues a treatment course initiated on [date], including letrozole dose escalation after an unresponsive cycle. I will reassess ovulatory response at the next monitoring visit and discuss transition to gonadotropins if two further cycles fail."

Sample attestation for recurrent pregnancy loss

"I am managing this patient's recurrent pregnancy loss (N96) on a longitudinal basis. Today I reviewed parental karyotypes and antiphospholipid antibody results ordered at the prior visit. Workup to date is unrevealing for a structural or genetic etiology. Plan: progesterone luteal support, early serial hCG and ultrasound surveillance in the next conception, and follow-up with me at first positive pregnancy test."

Both examples avoid boilerplate traps. They reference specific prior data, a decision made today, and a future touchpoint owned by the same practitioner. That pattern is the evidentiary core of a defensible G2211 claim. Practices can standardize these patterns using 1,000+ Specialty Clinical Macros tuned for REI workflows.

The G2211 audit map for REI clinics links every parameter to a documentation safeguard

The table below summarizes the clinical parameters most likely to be scrutinized on REI G2211 claims, what the record must show, where audits typically find weakness, and how the Scribing.io Clinical Interface structures the note to close that gap.

Four REI scenarios generate most G2211 audit findings

Nurse-led cycle monitoring visits are the most common error. Follicle-tracking encounters performed by nurses and reported as 99211 should not carry G2211 as a default. Under 2024 guidance, 99211 is technically an eligible base code, but the add-on still requires the longitudinal relationship with the billing practitioner and appropriate incident-to compliance. Most REI compliance teams choose to exclude 99211 from automated capture entirely.

Donor and gestational carrier encounters are the second risk area. An oocyte donor undergoing screening does not have an infertility diagnosis, and a gestational carrier clearance visit is not ongoing care of a serious condition belonging to that individual. Billing G2211 in these records is difficult to defend under any reading of the descriptor.

Post-transfer obstetric handoff is the third. Many REI practices follow pregnancies to roughly eight to ten weeks of gestation, then transfer care to obstetrics. Once the transfer is documented, the REI longitudinal relationship for infertility has ended. A return visit months later for a new treatment cycle can restart the relationship, but the note should say so explicitly.

Second-opinion consultations are the fourth. A patient who travels to your clinic for a one-time review of failed IVF cycles, with care returning to the home REI, does not meet the longitudinal criterion. If the patient elects to transfer care to you, document that decision in the visit where it happens.

Audit trigger: G2211 on every claim regardless of visit type.

ICD-10-CM sequencing must tell auditors which condition the relationship is built around

Claim-level diagnosis order matters. When G2211 is present, reviewers look at the first-listed diagnosis to judge whether a serious or complex condition is being managed. Place the condition code (N97.0, N96, E28.31x, N80.x) first, followed by etiology or comorbidity codes, then encounter-purpose Z codes.

Specificity also reinforces complexity. Coding N97.9 (female infertility, unspecified) on a patient with a completed workup showing anovulation undersells the condition and weakens the G2211 rationale. Upgrade to the most specific code the record supports, and document the findings that justify it.

Comorbidity capture has downstream value. Insulin resistance, obesity, hypothyroidism, and thrombophilia codes captured during REI care also feed risk models in Medicare Advantage and value-based contracts. The principles overlap with those described in AI Documentation HCC Risk Adjustment Scores, where accurate, specific diagnosis capture drives both compliance and appropriate reimbursement.

Sequencing example for a PCOS ovulation induction visit

• First position: N97.0, female infertility associated with anovulation.

• Second position: E28.2, polycystic ovarian syndrome.

• Third position: E88.81x or appropriate metabolic code if insulin resistance is documented.

• Fourth position: Z31.x encounter code reflecting the visit purpose, if payer requires it.

Medical directors should implement G2211 capture through a six-step rollout with measurable controls

Step one is payer validation. Build the payer policy matrix described above before turning on any automated suggestion. Capturing G2211 on plans that deny it creates rework, patient confusion, and avoidable write-offs.

Step two is eligibility logic. Configure charge capture so G2211 is suggested only when the base code is 99202 through 99215 (or 99341 through 99350), no Modifier 25 is present outside the preventive exception, the participant role is "patient," and an active longitudinal episode exists.

Step three is attestation standardization. Adopt one or two physician-approved attestation patterns per major diagnosis family. Require the four elements (condition, relationship, prior data, forward plan) and prohibit copy-forward of the attestation without updating the visit-specific content.

Step four is physician education. A thirty-minute session covering the Modifier 25 conflict, donor and carrier exclusions, and the obstetric handoff rule resolves most errors before they reach a claim. Revisit the material each January when the Physician Fee Schedule final rule takes effect.

Step five is prepayment review. For the first ninety days, route a sample of G2211 claims to a certified coder for review before submission. Ten percent is a reasonable starting sample. Expand review if error rates exceed five percent.

Step six is ongoing monitoring. Track the metrics below monthly and present them at the compliance committee meeting each quarter.

Key performance indicators for REI G2211 programs

• Eligible encounter capture rate: G2211 claims divided by encounters meeting all eligibility criteria.

• G2211 denial rate by payer: identifies plans with undocumented non-coverage policies.

• Modifier 25 conflict rate: claims where G2211 and Modifier 25 co-occurred before correction.

• Attestation completeness score: percentage of sampled notes containing all four required elements.

• Per-physician variance: outliers far above or below peer capture rates warrant chart review.

Target benchmark: under five percent G2211 error rate on prepayment review.

Structured documentation makes G2211 compliance a byproduct of good clinical notes

The strongest G2211 programs do not ask physicians to remember a billing rule at the end of every visit. They build the longitudinal evidence into the note structure itself, so the attestation reflects real clinical reasoning rather than appended boilerplate.

An ambient AI scribe configured for REI can recognize when a visit references a prior cycle, a pending test result, or a planned protocol change, then organize that content into the assessment and plan so the longitudinal relationship is visible. It can also detect when a same-day IUI or biopsy is being performed and withhold the G2211 suggestion before the claim is built.

Physician review remains mandatory. No documentation tool should finalize an attestation or add a billing code without the rendering practitioner's confirmation. The goal is to reduce clerical effort and surface errors early, not to remove clinical judgment from coding decisions.

Reproductive endocrinology is well suited to G2211 because its care model is inherently longitudinal: sequential testing, iterative treatment, and repeated risk counseling across months. Clinics that document that reality clearly, respect the Modifier 25 boundary, exclude donor and carrier encounters, and close episodes at obstetric handoff will capture the add-on appropriately and withstand review. Explore REI-ready templates and workflows through the Scribing.io Clinical Interface.

This playbook is operational guidance, not legal or coding advice. Confirm current CMS Physician Fee Schedule provisions, MAC guidance, and individual payer contracts before implementing billing changes in your practice.